Method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of pregnant woman

A technology for pregnant women's peripheral blood and nuclear red blood cells, which is applied in the field of non-invasive prenatal diagnosis to achieve efficient and high-specificity capture

Inactive Publication Date: 2015-11-18
石莹
View PDF5 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this kind of examination belongs to the morphological level, and can only detect whether the fetus is deformed, the diagnostic range is limited, and the sensitivity and accuracy of the diagnostic method are poor
Amniocentesis is the main method of invasive prenatal diagnosis. Amniocentesis requires the use of a long needle with a core to enter the amniotic cavity of pregnant women to extract amniotic fluid multiple times. This method is invasive and has certain risks for both the fetus and the pregnant woman. It is particularly easy to cause adverse complications such as intrauterine infection, miscarriage, and fetal death, and is not easily accepted by pregnant women and their families

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of pregnant woman
  • Method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of pregnant woman
  • Method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of pregnant woman

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] according to figure 1 The illustrated embodiment of the present invention uses nanomaterials to separate fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis. First, chemical modification methods (MPTMS, GMBS and Streptavidin are used to process the nano-substrates in sequence for 1 hour, 45 Minutes and 6 hours), and then drop the antibody with biotin group onto the substrate, and the nanoparticle 200 is combined with the antibody 201 to prepare a nanoparticle substrate modified with specific antibodies. The method of separating fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis firstly enters the step of capturing fetal nucleated red blood cells in the peripheral blood of pregnant women S1100: the venous blood of the pregnant women whose gestational age is 12 weeks and 3 days is collected from the hospital and stored in In the blood collection tube wit...

Embodiment 2

[0036] according to figure 1 The illustrated embodiment of the present invention uses nanomaterials to separate fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis. First, chemical modification methods (MPTMS, GMBS and Streptavidin are used to process the nano-substrates in sequence for 1 hour, 45 Minutes and 6 hours), and then drop the antibody with biotin group onto the substrate, and the nanoparticle 200 is combined with the antibody 201 to prepare a nanoparticle substrate modified with specific antibodies. The method for separating fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis firstly enters the step of capturing fetal nucleated red blood cells in the peripheral blood of the pregnant women. S1100: The venous blood of the pregnant women whose gestational age is 17 weeks and 4 days is collected from the hospital and stored in In the blood collection tu...

Embodiment 3

[0038] according to figure 1 The illustrated embodiment of the present invention uses nanomaterials to separate fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis. First, chemical modification methods (MPTMS, GMBS and Streptavidin are used to process the nano-substrates in sequence for 1 hour, 45 Minutes and 6 hours), and then drop the antibody with biotin group onto the substrate, and the nanoparticle 200 is combined with the antibody 201 to prepare a nanoparticle substrate modified with specific antibodies. The method of separating fetal nucleated red blood cells from the peripheral blood of pregnant women for non-invasive prenatal diagnosis first enters the step of capturing fetal nucleated red blood cells in the peripheral blood of pregnant women S1100: the venous blood of the pregnant women whose gestational age is 28 weeks and 2 days is collected from the hospital and stored in In the blood collection tube with ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of a pregnant woman. The method comprises the following steps: 1, preprocessing fresh pregnant woman maternal peripheral blood: separating and enriching monocytes containing fetal nucleated red blood cells from maternal peripheral whole blood through a density gradient centrifugation technology; 2, capturing cells: adding a separated monocyte suspension to a substrate chip modified with an antibody, and carrying out standing capturing; and 3, identifying the sex of a fetus: identifying whether the nucleated red blood cells of the captured fetus contain Y chromosome or not by using an FISH probe technology (CSP-X / Y). The method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of the pregnant woman can realize capture and identification of the fetal nucleated red blood cells from the maternal peripheral circulating blood, and allows the FISH analysis to be directly carried out in order to realize noninvasive antenatal diagnosis of the sex or 21-Trisomy syndrome and other chromosome diseases of the fetus.

Description

Technical field: [0001] The present invention involves a method of non -invasive prenatal diagnosis, and especially involves a method that uses nano -materials to capture the fetus from the peripheral blood of pregnant women with nuclear red blood cells for non -invasive prenatal diagnosis. Background technique: [0002] Preparatory diagnosis, also known as diagnosis or intrauterine diagnosis before birth, refers to the application of modern biology, biochemical, immunogenic genetic, cell genetic, molecular geneticism and other technologies before the fetus is born.Detection to understand the appearance of the fetus, perform nuclear analysis of the fetal chromosomes, detect the biochemical component of the fetal cells, or generate a genetic analysis of it, so as to make a timely diagnosis of congenital malformations or hereditary diseases of some fetuses to prevent seriousnessThe birth of genetic diseases, intellectual disorders, and congenital malformed fetuses.Therefore, prena...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
CPCC12Q1/6834C12Q2565/518
Inventor 石莹
Owner 石莹
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products